A Two Part, Phase 1/2, Safety, PK and PD STudy of TOL101, an Anti-TCR Monoclonal Antibody for Prophylaxis of Acute Organ Rejection in Patients Receiving Renal Transplantation

  • Waid, Thomas (PI)

Grants and Contracts Details

StatusFinished
Effective start/end date12/9/10 → 5/31/14